Document is current

Any future updates will be listed below

Apalutamide versus bicalutamide in combination with androgen deprivation therapy for metastatic hormone sensitive prostate cancer

Crossref DOI link: https://doi.org/10.1038/s41598-024-51389-w

Published Online: 2024-01-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark